Drug Shortage Report for TARO-MELPHALAN
Report ID | 222087 |
Drug Identification Number | 02480026 |
Brand name | TARO-MELPHALAN |
Common or Proper name | melphalan |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BUFFER SOLUTION MELPHALAN |
Strength(s) | 10ML 50MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRA-ARTERIAL |
Packaging size | 1 |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-01 |
Estimated end date | 2024-03-28 |
Actual end date | 2024-04-01 |
Shortage status | Resolved |
Updated date | 2024-05-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-05-07 | French | Compare |
v3 | 2024-05-07 | English | Compare |
v2 | 2024-03-13 | French | Compare |
v1 | 2024-03-13 | English | Compare |
Showing 1 to 4 of 4